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What is the evidence on the susceptibility and transmission of children and young people to SARS-
CoV-2 in comparison with adults? 
 
Findings 
Children and young people under 18-20 years had an 43% lower odds of secondary infection of with 
SARS-CoV-2 compared with adults, a significant difference. This finding was most marked in children 
under 12-14 years. Data were insufficient to conclude whether transmission of SARS-CoV-2 by 
children is lower than by adults.  
 
Meaning  
We found preliminary evidence that children have a lower susceptibility for SARS-CoV-2 infection 







The degree to which children and young people are infected by and transmit the SARS-CoV-2 virus is 
unclear. The role of children and young people in transmission of SARS-CoV-2 is dependent on 
susceptibility, symptoms, viral load, social contact patterns and behaviour.  
 
Objective 
We undertook a rapid systematic review to address the question “What is the susceptibility to and 
transmission of SARS-CoV-2 by children and adolescents compared with adults?”  
 
Data sources 
We searched PubMed and medRxiv up to 28 July 2020 and identified 13,926 studies, with additional 
studies identified through handsearching of cited references and professional contacts.  
 
Study Selection 
We included studies which provided data on the prevalence of SARS-CoV-2 in children and young 
people ( <20 years) compared with adults derived from contact-tracing or population-screening. We 
excluded single household studies.  
 
Data extraction and Synthesis 
We followed PRISMA guidelines for abstracting data, independently by 2 reviewers. Quality was 
assessed using a critical appraisal checklist for prevalence studies. Random effects meta-analysis was 
undertaken. 
 
Main Outcomes  
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 Secondary infection rate (contact-tracing studies) or prevalence or seroprevalence (population-
screening studies) amongst children and young people compared with adults.  
 
Results 
32 studies met inclusion criteria; 18 contact-tracing and 14 population-screening. The pooled odds 
ratio of being an infected contact in children compared with adults was 0.56 (0.37, 0.85) with 
substantial heterogeneity (95%). Three school contact tracing studies found minimal transmission by 
child or teacher index cases. Findings from population-screening studies were heterogenous and 
were not suitable for meta-analysis. The majority of studies were consistent with lower 
seroprevalence in children compared with adults, although seroprevalence in adolescents appeared 
similar to adults. 
 
Conclusions 
There is preliminary evidence that children and young people have lower susceptibility to SARS-CoV-
2, with a 43% lower odds of being an infected contact. There is weak evidence that children and 
young people play a lesser role in transmission of SARS-CoV-2 at a population level. Our study 
















The degree to which children and young people under 20 years are infected by and transmit the 
SARS-CoV-2 virus is an unanswered question.1-3 These data are vital to inform national plans for 
relaxing social distancing measures including reopening schools.  
 
Children and young people account for 1-3% of reported cases across countries4-8 and an even 
smaller proportion of severe cases and deaths.5,9 Children appear more likely to have asymptomatic 
infection than adults and analyses based upon symptom-based series underestimate infections in 
children.  
 
The role that children and young people play in transmission of SARS-CoV-2 by is dependent upon 
their risk of exposure, their probability of being infected upon exposure (susceptibility), the extent to 
which they develop symptoms upon infection, the extent to which they develop a viral load 
sufficiently high to transmit and their propensity for making potentially infectious contact with 
others, dependent upon numbers of social contacts across age-groups and behaviour during those 
contacts.  
 
Different study types may provide useful information on susceptibility and transmission in children 
compared with adults, yet each is open to bias. Contact-tracing studies with systematic follow-up of 
all contacts to estimate secondary attack rates (SAR) in children and adults can provide strong 
evidence on differential susceptibility. Findings from some contact tracing studies suggest that 
children have lower SARS-CoV-2 SAR than adults,10 although others have found no difference by 
age.11 One study from South Korea has suggested adolescents but not children may have higher 
SAR,12 although a separate analysis of child cases from the same population identified minimal 
transmission from these cases.13 
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Population-screening studies may identify infection through viral RNA detection or antibodies 
indicating prior infection. However the prevalence of SARS-CoV-2 in children in a population is not a 
direct indicator of susceptibility or transmission as the expected prevalence depends on exposure, 
susceptibility, proportions of children in the population, mixing rates among children and between 
adults and children and timing of social distancing interventions that disrupt mixing.  
 
A number of authors have concluded that children and young people may be less susceptible to 
SARS-CoV-2,2,14 although there are multiple sources of bias in each study type which can complicate 
straightforward analysis. In contact-tracing studies, testing of only symptomatic contacts will 
introduce significant bias, as will seroprevalence studies drawn from clinical contact studies (e.g. 
primary care) or residual laboratory sera. Many studies undertaken quickly during the pandemic are 
under-powered to identify age-differences.   
 
We undertook a systematic review and meta-analysis of published and unpublished literature to 
assess the susceptibility to SARS-CoV-2 in children and adolescents compared with adults. We 
limited this review to contact-tracing studies and population-based studies as these are likely to be 





Our review question was “What is the susceptibility to SARS-CoV-2 by children and adolescents 
compared with adults?”  
 
We undertook a rapid systematic review and included contact tracing studies or prevalence studies 
in published or preprint form and including data from a national public health website reporting 
government statistics and studies. Studies were required to provide data on proven SARS-CoV-2 
infection (PCR or serology) and report either rate of secondary infections in children and young 
people compared with adult or infection prevalence or seroprevalence in children and adolescents 
separately to adults.  
 
We excluded reports of single household/institution outbreaks; studies of hospitalised patients, 
clinical studies and cohorts defined by symptoms; studies of unconfirmed cases i.e. cases based on 
self-report or symptoms, including contact-tracing studies where only symptomatic contacts were 
traced; modelling studies or reviews unless these reported new data ; and prevalence studies with 
ascertainment based upon clinical contact and seroprevalence studies of residual sera, as these are 
likely to under-represent children 
 
Where studies were drawn from populations that overlapped, we excluded studies where the time 
periods overlapped but included studies where time-periods did not overlap. We did not include in 
this review seroprevalence studies only in children as these did not allow comparison with adults.  
 
We searched two electronic databases, PubMed and the medical preprint server medRxiv on 16 May 
2020 and updated this on 28 July 2020. We used the following search terms in PubMed: ("COVID-
19"[tw] OR "2019-nCoV"[tw] OR "SARS-CoV-2"[tw]) AND ((child* OR infant*) OR (“transmission”[tw] 
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OR "transmission" [mh]) OR ("Disease Susceptibility"[tw] OR “susceptibility”(mh)) OR 
(“epidemiology”[tw] OR "epidemiology" [mh]) OR (“contact tracing”[tw] or “communicable disease 
contact tracing”[mh])). In medRxiv we undertook separate searches for ‘child and covid-19’, ‘covid-
19 and epidemiology’, ‘covid-19 and susceptibility’ and ‘covid-19 transmission’ as more complex 
Boolean searches are not available.  
 
Figure 1 shows the PRISMA flow diagram .  
 
One researcher (RV) screened studies on title and abstract to identify potentially eligible studies for 
full-text review. Full text studies were then reviewed by two researchers for eligibility and data were 
extracted independently by two researchers (RV and OM or CW).  We hand-searched cited 
references in all potentially eligible studies for additional studies and identified additional studies 
through authors’ professional networks.  
 
Data were extracted on country, study type, study context with regards social distancing measures 
and school closures at the time of the study, case definition, testing method, sampling method, and 
infection rates in adults and children.  
 
Methodological quality of included studies was assessed independently by 3 authors (OM, CW, RV) 
based on a critical appraisal checklist for prevalence studies.15 We assessed risk of bias using two 
additional criteria: whether symptomatic contacts (in contact-tracing studies) or individuals 
(population-screening studies) were more likely to participate than asymptomatic ones; and 
whether the obtained sample was >75% of the intended sample. Studies were categorised as high 
quality if they met all quality criteria and had low risk of bias on both criteria; medium if they had 
low risk of bias on 1 or more criteria and met ≥5 of 7 quality criteria; low if they had met <5 quality 




Contact tracing and population prevalence studies were considered separately. Random effects 
meta-analysis with restricted maximum likelihood estimation was undertaken using the meta 
commands in Stata 16 (StataCorp; College Station, TX). Odds ratios were used as the primary metric 
for contact tracing studies. Prevalence ratios were used as the primary metric in population-based 
studies. We planned subgroup analyses using restricted maximum likelihood based upon quality of 
study and age of children / adolescents.  
 
We followed the PRISMA guidelines in reporting findings.  
 




The PubMed search resulted in 3465 and the medRxiv search in 10,461 studies, of which 113 and 90 
respectively were examined in full text and 16 studies included (Figure 1). We identified a further 6 
studies through reference-checking and 10 studies through professional networks. In total 32 studies 
were included (Table 1) with quality/bias assessments shown in eTable 1. Eighteen were contact-
tracing studies (CTS) (3 were school CTS), and 14 were population-screening studies. Two were high 
quality, 22 medium, 7 low and one uncertain.  
 
Contact tracing studies  
Six were from mainland China, two from the USA and one each from Taiwan, Japan, South Korea, 
Israel, the Netherlands, Brunei and India, with school CTS from Australia, the Ireland and Singapore.  
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Lower secondary attack rates (SAR) in children and young people compared with adults were 
reported by 11 studies; 5 from provinces of China, including Hunan,10,16 Hubei,17,18 and Beijing;19 and 
6 studies from other countries, including Taiwan,20 Japan,21 the USA,22,23 Israel24 and the 
Netherlands,7,25 although confidence intervals were wide in some studies. 
 
No significant differences in SAR by age were reported in four studies: from Guangdong province, 
China,26 Brunei27 and the states of Tamil Nadu and Andhra Pradesh in India28 with one study from 
South Korea reporting high SAR in <19 year-olds.12 In three of these, SAR in younger children were 
low compared with adults but those amongst teenagers were as high as or higher than adults. 12,27,28   
 
We undertook a random effects meta-analysis of SAR in children and young people compared with 
adult, with data able to be included from 14 studies. We combined data on children and young 
people <20 years and adult age-groups >20 years, thus odds ratios (OR) and prevalence rates for 
adults may differ from those reported in studies. The pooled OR estimate for all contact-tracing 
studies of being a child with secondary infection compared with adults was 0.56 (0.37, 0.85) with 
high heterogeneity (95%) (Figure 2).  
 
In meta-analysis of 8 CTS grouped by age of child (Figure 3), the pooled OR for children <12-14 years 
was 0.52 (0.33, 0.82), significantly lower than adults, whereas for adolescents this was non-
significant (OR=1.23 (0.64, 2.36). Chi-square test suggested this group difference was significant (chi-





When only the 8 medium/high-quality (low risk of bias) studies were examined, this finding was no 
longer significant (OR 0.68 (0.41, 1.11), however the difference in estimates between low and 
medium/high quality studies was not significant  (p=0.202). (see eFigure 1). 
 
We hypothesised that CTS including only household contacts might provide a clearer indication of 
the relative susceptibility to infection of children versus adults because all contacts within 
households might be assumed to receive a similar exposure to infection from index cases. A post-
hoc analysis by type of contacts (eFigure 2) showed studies of household contacts gave a lower 
pooled odds ratio (0.41 (0.22, 0.76)) than did studies of all contacts (0.91 (0.69, 1.21)) (between 
group variance; df=1, chi2= 5.31, p=0.021).  
 
Three studies undertook contact-tracing in schools. A state-wide population-based CTS in 
educational settings in Australia before and during school closures29 found that 27 primary cases 
(56% staff) across 25 schools or early-years nurseries resulted in 18 secondary cases in 4 settings, 
including an outbreak of 13 in one early-years setting initiated by a staff member with no evidence 
of child to adult transmission. The SAR was 1.2% (18/1448) overall, 5/1411=0.4% excluding the early-
years outbreak and 2.8% (18/633) in those tested. Other national CTS undertaken in schools in the 
Republic of Ireland30 and Singapore31 before schools closed identified very few secondary cases in 
schools.  
 
Population screening studies 
Data from prevalence studies for children and young people compared with adults is shown in Figure 
4. We did not undertake a meta-analysis of population-screening studies, given the important 
differences in the populations, epidemic time-points and methodologies involved.  
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Four studies reported virus prevalence. National prevalence studies from Iceland32 and Sweden33 
undertaken while primary schools were open, showed lower prevalence amongst children and 
young people than adults, as did a municipal study from Italy34 undertaken just before lockdown 
while schools were open. However a nationally-representative survey from England covering 
lockdown and the subsequent month identified no significant differences by age.35  
 
10 studies reported seroprevalence, 3 being nationally representative. A lower seroprevalence was 
identified in children and in some instances adolescents compared with adults in a number of 
studies, including a nationally representative study in Spain (ENE-COVID-19),36 a Dutch nationally-
representative study (Pienter Corona study),7,37 and city or regional studies from Iran,38 the USA,39 
Switzerland40 and Japan41 although no difference by age was found in a survey in 133 sentinel cities 
in 26 Brazilian states.42 Two community-based studies following localised outbreaks found lower 
seroprevalence amongst children and young people than adults in Lombardy, Italy43 and Thuringia, 
Germany,44 with a second German post-outbreak study finding no overall association with age.45  
 
Examination of seroprevalence findings in children separately to adolescents (eFigure 3) suggested 
that seroprevalence lower than adults amongst younger children (<10 years) but not in  adolescents, 
although this was not formally tested.   
 
Discussion 
We identified 37 studies from 23 countries that met our eligibility criteria and provided information 
on susceptibility to and transmission of SARS-CoV-2 in children and young people compared with 
adults. We excluded studies and study types open to very significant bias, yet studies were 
predominantly of medium and low quality, with only two high quality studies. The majority of 
studies were from middle and high-income countries in East Asia and Europe.  
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We found preliminary evidence from 15 contact-tracing studies that children and young people have 
lower susceptibility for SARS-CoV-2 infection than adults, with a pooled odds ratio of 0.57 (0.39, 
0.83). This estimate was little changed when only medium or high quality studies were examined, 
although power was reduced and the confidence interval included one. Only one study13 found a 
higher odds of infection in 0-19 year olds than adults, although this finding was confined to 10-19 
year olds. When studies were categorised by age of the children, lower susceptibility appeared to be 
confined to younger children (less than 14 years), who had a 48% lower odds of infection compared 
with adults aged ≥20 years. The age bands of the studies were not aligned making direct 
comparisons challenging.  
 
Data from population-screening studies were heterogenous and were not suitable for meta-analysis. 
Findings consistent with lower seroprevalence in 0-19 year olds compared with adults were reported 
by two national studies, one regional study and all of the municipal post-outbreak studies, although 
confidence intervals were wide in some cases. Two virus prevalence studies similarly reported lower 
infection rates in ≤20 year-olds. In contrast, other studies reported no age-related differences. No 
studies reported higher prevalence in children and adolescents. Examination of seroprevalence 
findings in children separately to adolescents showed that the majority of studies were consistent 
with lower seroprevalence in children compared with adults, although seroprevalence in 
adolescents appeared similar to adults in all studies.  
 
The findings from the CTS and prevalence studies are largely consistent in suggesting that children 
below approximately 12-14 years are less susceptible to SARS-CoV-2 infection, resulting in lower 
prevalence and seroprevalence than adults. Data specifically on adolescents are sparse although 
consistent with susceptibility and prevalence more similar to adults. Our findings on susceptibility 
are similar to a modelling analysis by Davies et al.,46 who estimated that those under 20 years were 
approximately half as susceptible to SARS-CoV-2 as adults.  
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We found few data that were informative on the onward transmission of SARS-CoV-2 from children 
to others. Data from the large Australian school contact-tracing study suggest that, at a population 
level, children and young people might play only a limited role in transmission of this pandemic. This 
is consistent with the data on susceptibility noted above, i.e. suggesting that lower rates of 
secondary infection mean that children and young people have less opportunity for onward 
transmission. There is evidence of transmission from children to others in households and in schools, 
and there have been reported outbreaks in schools.47,48 Other very small studies in Ireland30 and 
Singapore31 have found low numbers of secondary cases resulting from infected children attending 
school. This is consistent with a national South Korean study, which found the SAR from children to 
household members was extremely low.13 The available studies suggest children and young people 
play a lesser role in transmission of SARS-CoV-2, in marked contrast to pandemic influenza.49  
 
Limitations 
Our study is subject to a number of limitations. We remain early in the pandemic and data continue 
to evolve. It is possible that unknown factors related to age, e.g. transience of infection or waning of 
immunity, bias findings in ways we don’t yet understand. Some studies were low quality and nearly 
all included studies were open to bias. The secondary infection rate in some CTS was low and this 
may represent an underestimate of the unmitigated household attack rate of SARS-CoV-2 as 
transmission chains were cut short because of strict control measures.50 Most of the CTS were 
undertaken when strict social distancing measures had been introduced, e.g. closures of schools and 
workplaces, restriction of travel. This would have reduced contacts outside the home, especially 
contacts between children, but it may have increased contacts between children and adults by 
increasing the household contact rate. The number of contacts nominated and traced for 0-19 year 
olds was low compared with adults in some studies,12,28 which may have introduced bias. We 
identified 3 CTS from Guangdong province11,51,52 which were excluded as they overlapped with Liu et 
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al.,26 however findings were unchanged if these studies were included. We included two recent large 
CTS from India28 and South Korea12 however numbers of children and data quality appeared low, 
making firm conclusions difficult. 
 
For population screening studies, the numbers of children tested was small in most of the studies, 
and was frequently less than the 15-25% of the population that are < 18 years in most countries. 
This likely reflects lower recruitment of children and may be a source of bias, although the direction 
of this bias is unclear. Age-differentials in sensitivity of swab or antibody tests may also confound 
findings. Interpreting the observed prevalence and seroprevalence studies requires thorough 
quantification of social mixing and transmission between age groups and how that changed during 
lockdowns and social distancing interventions. 
 
Summary and implications  
There is preliminary evidence that children under 12-14 years have lower susceptibility to SARS-CoV-
2 infection than adults, with adolescents appearing to have similar susceptibility to adults. There is 
some weak evidence that children and young people play a limited role in transmission of SARS-CoV-
2  however this is not directly addressed by our study.  
 
We remain early in our knowledge of SARS-CoV-2 and further data are urgently needed, particularly 
from low-income settings. These include further large, high quality contact-tracing studies with 
repeated swabbing and high-quality virus-detection and seroprevalence studies. Studies which 
investigate secondary infections from child or adolescent index cases in comparison to secondary 
infections from adult index cases are particularly needed in order to assess transmission. Monitoring 
of infection rates and contact-tracing studies within child-care and school settings will also be 
important. A range of serological studies are planned in many countries and these need to be 
sufficiently powered to assess differences in seroprevalence across different age groups and include 
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repeated sampling at different time periods as social distancing restrictions are lifted. We will 
continue to update this review, including further data as available and updating preliminary data 
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Figure 1. PRISMA flow diagram for search   
 
Figure 2. Pooled estimate of odds of being an infected contact among children compared with adults 
for all contact tracing studies 
 
 
Figure 3. Pooled estimate of odds of being an infected contact among children and among 
adolescents compared with adults for contact tracing studies  
 
 
Figure 4. Ratios of the prevalence of SARS-CoV-2 infection in children and young people compared 





Table 1. Characteristics of included studies 
A. Contact-tracing studies       
Author Status Location Recruitment of index cases Recruitment and isolation of contacts Contact type Number of clusters, index 
cases and contacts 
Case 
definition/testing 
Age: child / adult 
Zhang et al.10 Published 
& peer 
reviewed 
Hunan, China All confirmed cases identified by Hunan 
CDC between 16 January and 1 March 
2020. 
January 16, 2020 to March 1, 2020. 
Close contacts were identified through 
contact tracing of a confirmed cases 
and placed under medical observation 
for 14 days. A close contact is defined as 
an individual who had unprotected 
close contact (within 1 meter) with a 
confirmed case or an asymptomatic 
infection within 2 days before their 
symptom onset or sample collection. 
All contact types 114 clusters representing 136 
index cases & 7193 contacts.  
 
]One (0.7%) index case was <15 
years. 
RT-PCR positive 
All close contacts were 
tested in accordance 
with local policy 
regardless of 
symptoms. % of 
contacts tested not 
stated.  
  
0-14y / 15+y 








Index cases identified from two 
hospitals (in Zaoyang City and Chibi 
City) to 13 February 2020. Index cases 
were excluded if members of their 
family had links to Wuhan. Not clear if 
all cases from hospital were sampled or 
just a sub-set. 
1 January to 13 February 2020. All 
household contacts were quarantined 
immediately for 14 days by the local 
government and monitored daily.  
Household 
contacts 
105 index patients with their 
households (n=105) and all 
family contacts (n=392). 
 
The proportion of index cases 
who were children was not 
reported. 
RT-PCR positive  
Nasopharyngeal swab 
samples were 
collected at the 
beginning and the 
middle of quarantine. 
100% of contacts 
tested 2-4 times.  
0-17y / 18+y 
Cheng et al.20 Published 
& peer 
reviewed 
Taiwan The initial 100 confirmed cases in 
Taiwan between 15 January and 18 
March 2020. 
Close contacts were identified through 
epidemiological investigation and 
defined as a person who did not wear 
appropriate personal protection 
equipment (PPE) while having face-to-
face contact with a confirmed case for 
more than 15 minutes during the 
investigation period (defined by 
epidemiological investigation and 
typically up to four days prior to 
symptom onset or test date for 
asymptomatic cases). All close contacts 
were quarantined at home for 14 days 
after their last exposure to the index 
case. 
All contact types 100 index cases; 2761 close 
contacts. 
 
The youngest index case was 
age 11 years although the 
proportion of index cases that 
were children was not 
reported. 
RT-PCR positive.  




Other contacts (69.3% 
) were only tested if 
symptomatic.  
0-19y / 20+y 
Wang et al.17 Published 
& peer 
reviewed 
Wuhan, China Patients hospitalized in Union Hospital 
(n=85) on 13 and 14 February. Not clear 
if all cases from hospital were sampled 
or just a sub-set. 
Household contacts of the hospitalised 
patients, followed for 14 days. 
Household 
contacts 
They enrolled 85 households 
corresponding to the 85 
patients and identified 155 
household contacts. 
RT-PCR positive 
Throat swabs. Process 
for testing household 
members not stated, 
but 33% of household 
Child age not 
defined.  
 26 
contacts were not 
tested for SARS-CoV-2 
Mizumoto et 
al.53 
Preprint Japan Cases that were domestically acquired 
and confirmed by RT-PCR by 7 March 
2020 
Contacts of index cases, definition and 
method of ascertainment not given. No 
details on isolation of contacts. 
Not stated. the 
total number of 
contacts (8 per 
index case) 
suggests these are 
likely all contacts. 
313 cases and their 2496 close 
contacts.  
 
RT PCR positive. 
Process and eligibility 
for testing of contacts 
not described. 
0-19y / 20+y 





Beijing, China All laboratory-confirmed (RT-PCR) cases 
in Beijing up to 21 February 2020, 
recruited through Beijing CDC.  
28 February and 8 March 2020. All 
household members of index cases 
were followed for 14 days. Testing and 




124 of 137 eligible families 
participated.  
 
No primary cases were <18y. 
Index and secondary 
cases defined by RT-
PCR positive. 
Proportion of PCR 
testing of secondary 
contacts is not stated.   
 
Park et al.12 Published 
and peer 
reviewed 
South Korea All laboratory-confirmed cases in Korea 
registered with Korea CDC from 20 
January to May 13. 
All contacts of index cases registered 
with Korea CDC through a 
comprehensive national contact-tracing 





only data on 
household 
contacts included 
in this review. 
Studied 59,073 contacts 
(10,592 were household 
contacts) of 5706 index cases. 
Only included Index cases who 
reported 1 or more contact 
however only included 52% of 
10,962 national cases reported 




tested by RT-PCR.  
Other contacts only 




Preprint Israel Identification of all households in city of 
Bnei Break where all household 
members had been tested (PCR) and 1 
or more member was positive. 
Households identified through the 
Israeli COVID-19 database until 2 May 
2020.  
 
All household members included.  
 
Note 51% of population is < age 20 
years.  
Household 637 houses comprising 3353 
people of whom 1510 were 
positive. All eligible households 
were included.  
 
The figures included in our 
systematic review were 
derived from supplied 
estimated probabilities of 
children or adults being the 
index.  
RT-PCR testing of all 
household members 
including index cases 
and contacts.  
 
Hu et al.16 Preprint Hunan, China All cases with contact details were 
identified from the notifiable infectious 
diseases reporting system in Hunan 
Province. 16 Jan to 2 April 2020. 
Contacts were quarantined for 14 days 
and tested (PCR) at least once during 
quarantine: after 7 Feb all contacts 
were tested but only symptomatic 
contacts tested before 7 Feb (approx. 
50% of contacts tested). 









Index cases identified from state 
registries and contacts traced by public 
health agencies in each state- 5 March 
to 4 June (to 29 May in A.P).  
 
Contacts traced by public health 
agencies and tested between 5-15 days 
of exposure. Insufficient detail 
provided. Note that there were twice as 
All contacts 4206 confirmed cases and 
64,031 contacts. 
 
Note only 4206 cases included 
out of 33,584 total cases =13%, 





many close contacts per index case 
<18y compared with >18y.  
with no detail given on non-
recruitment.  
 






All cases identified by intensive regional 
surveillance by local CDC from 15 Jan to 
15 March 
Contacts traced and monitored with PCR 
from throat swabs taken every few days 
for 14 days;  84% of contacts were 
quarantined in centralised stations.  
All contacts 1361 cases reported and 
11,868 contacts traced and 
quarantined. Analysis included 
11,580 contacts (98%).  













Identified and studied 229 initial 
confirmed (PCR) cases in NY State 
outside of NY City from 2 to 12 March. 
Active contact tracing by county and 
state health departments. All household 
contacts were eligible for PCR testing. 
Contacts tested 0-10 days after index 
case (43% were tested on Day 0 i.e. 
initial index diagnosis day).  




All household contacts 
were eligible for PCR 










Salt Lake City 
(Utah), USA 
All PCR-positive cases from two cities 
were identified through routine public 
health surveillance and recruited 
between 22 March and 22 April.  
Active contact tracing by public health 
departments.  
All contacts were observed for 14 days 
with two swab tests (RT-PCR) on day 0 
and day 14 plus if symptomatic.  
Household 195 of 198 contacts 
participated (98.5%).  
 




All household contacts 
tested.  
 
Chaw et al.27 Preprint Brunei All 71 initial cases in Brunei, which 
arose following a religious event, with 
cases detected after 9 March 2020. 
Detailed contact tracing by Ministry of 
Health, with RT-PCR testing of all 
reported contacts. All contacts were 
quarantined for 14 days and retested if 
symptomatic.  
All contacts 71 index cases and 1755 close 
contacts. All contacts 
participated.  
RT-PCR  





Netherlands National surveillance data from two 
Dutch systems 
A. Osiris: registry of all laboratory-
confirmed cases 
B. HP Zone: data on contact tracing 
from 23 of 25 Dutch municipalities 
(GCDs). 
Data included to 2 April. 
 
Contact-tracing was undertaken for all 
cases registered in HPZone. Contact 
infection status identified through 
linkage to the main national 
surveillance database, suggesting that 
only symptomatic secondary cases were 
included.  
All contacts 231 cases and 709 close 
contacts.  
 
















COVID-19 cases in 25 educational 
settings (15 schools & 10 early learning 
centres) for which a person (student or 
staff) with proven COVID-19 (PCR 
positive) had attended while infectious. 
Identified through state Notifiable 
Conditions Information Management 
System. Schools remained open but 
25 Jan to 9 April 2020.  Followed up all 
close contacts (a person who has been 
in face to face contact for at least 15 
minutes or in the same room for at least 
40 minutes with a case while 
infectious). All close contacts followed 
and tested if symptomatic during the 14 




27 primary cases (12 student; 
15 staff cases) and their 1448 
school/early learning-related 
close contacts from 25 
educational settings.  
 
12 high school cases (8 
students; 4 staff) from 10 
RT PCR or serology 






6w-18y / 20y+ 
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C. Population-screening studies       
Author Status Location Context Recruitment  Timing of 
survey  






Iceland  First infection diagnosed 
on 28 February 2020; 
Containment measures 
put in place. Primary 
schools open but some 
secondary schools closed 
and moderate restrictions 
on social contacts from 13 
March. 
13 March to 6 April 2020. National population 
screening. Open invitation for 87% of participants 
through online portal but with collection of sample 
from one location (Reyjkavik), and random 
invitation for a sub-sample (13%). Children <10y 
made up 6.4% of sample.  
 
Participation in the study was primarily by request 
of participants rather than by random sampling, 





sample reported here. 
RT-PCR on nasopharyngeal and 
oropharyngeal samples. 








Quarantined community in 
an area of Italy that was 
affected early and severely 
All age groups were homogeneously sampled with 
age-specific percentages ranging from 70.8% to 




We present data only from 
this first survey although 
the paper also reports a 
RT-PCR on nasopharyngeal 
samples. 
0-20y / 21+y 
students dismissed from 23 March (<5% 
student attendance).  Note that school 
attendance remained high at the time 
that secondary cases were identified in 
schools, and early-years settings did not 
close.  
 
7 settings had testing of all contacts 5-
10 days after last contact plus serology 
after day 21.  
schools had a total of 695 
contacts (598 students; 97 
staff). The 5 primary school 
cases (1 student; 4 staff) from 
5 schools had a total of 218 
contacts (179 student; 39 staff) 
1448 contacts identified; 
663(43.5%) were tested (PCR 




Swabs taken from 
542/1,448 contacts 













Screened the Republic of Ireland 
national surveillance to identify all PCR-
positive cases in children or adults who 
attended school settings in period 
before schools were closed on March 
12 2020. 
1-12 March 2020. Contacts traced and 
advised to quarantine at home for 14 




6 index cases identified (3 
adult; 3 <18y).  
 
1155 contacts identified (924 
child; 101 adult).  
RT-PCR testing if 
symptomatic 
0-17y /18y+ 
Yung et al. Published 
and peer 
reviewed 
Singapore 3 potential SARS-CoV-2 seeding 
incidents in educational settings in 
Singapore identified from national 
surveillance during February and March 
2020.   
Feb to March 2020. Close school 
contacts (e.g. classmates) quarantined 
for 14 days. Contacts in 1 school and 1 
preschool were tested only if 
symptomatic; these schools were not 
closed. Contacts in 1 preschool were 
tested (PCR) after an outbreak causing 
school closure.  
School contacts 
only 
Three PCR-positive child index-
cases were identified from 2 
preschools and 1 secondary 
school. 
 
188 contacts studied, of whom 
119 (63%) were tested.  
RT-PCR 1-16y 
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C. Population-screening studies       
Author Status Location Context Recruitment  Timing of 
survey  
Note Case definition/testing Age: child / adult 
in the epidemic; area was 
‘locked down’ from the 23 
February for two weeks. 
Study undertaken close to 
the imposition of very 
strict social distancing 
measures in the region. 
included here (overall response rate 85.9%).  
Those <21y made up 17% of sample and had a 
participation rate of 94% (0-10y) and 95% (11-20y) 





Online report Sweden First death reported in 
Stockholm on 11 March 
2020. Voluntary social 
distancing measures 
recommended from 16 
March 2020, with 
secondary schools 
recommended to teach 
virtually. Primary schools 
and early years settings 
remained open 
throughout. 
Two nationally-representative surveys undertaken 
by the Swedish Public Health Agency, 
Folkhälsomyndigheten.  
 
Participants invited by email: 2571/4480 (57%) 
participated in April and 2957/4487 (66%) in May.  
 
Children 0-15y made up 18.9% of the April and 
17.2% of the May sample 
 






 RT-PCR on nasopharyngeal 
samples. 
0-15y / 16+y 
UK ONS35 Online report England Strict national social 
distancing measures 
enacted 20 March 2020, 
with gradual easing of 
lockdown from 25 May. 
Representative sample of 35,801 individuals in 
England. Those 2-19y made up 17% of the 
population. Cases were identified by home self-
sampling using nasopharyngeal swabs with carers 
swabbing young children. 
 





Repeated surveys carried 
out each week. Data 
shown here are the 
cumulative prevalence of 
those ever positive 
between 26 April-27 June. 
RT-PCR on nasopharyngeal 
samples. 
2-19y / 20+y 
Pollan et al. 
ENE-COVID-
1936 
Online report Spain Strict social distancing was 
imposed on 14 March 
2020. Some restrictions 
were lifted on 27 April and 
further restrictions lifted 
on 11 May.  
Undertaken by Spanish Ministry of Health. National 
representative sample obtained from random 
sampling of households in municipalities across 
Spain. 61,075 participants provided point of care 
samples (59%) and 51,958 included in both 




Those 0-19 years (n=11,464) made up 23% of the 
point of care sample and 12.6% of the 
immunoassay sample.  
27 April - 
11 May 
2020 
We used the point of care 
data here due to the 
sample being 
representative of the child 
population, unlike the 
immunoassay test. 
Point of care test: rapid 
immunochromatography IgG: 
Orient Gene, Zhejiang Orient Gene 
Biotech.  
Immunoassay: Abbott IgG serology.  
 
Comparison of the rapid test IgG 
with SARS-CoV-2 serology in 16,953 
of the study sample found 97.3% 
agreement between tests. 
0-19y / 20+y 
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C. Population-screening studies       
Author Status Location Context Recruitment  Timing of 
survey  
Note Case definition/testing Age: child / adult 
Netherlands 
Pienter7 
Online report Netherlands Social distancing measures 
introduced gradually from 
11 March 2020. Schools 
closed from 15 March.  
Undertaken by the Netherlands National Institute 
for Public Health and the Environment (RIVM). 
Population-based sampling was undertaken in a 
random sample of a randomly chosen subset of 
municipalities across the Netherlands. Total 
sample of 2096. Those <20y made up 20% of 
sample.  
31 March 
- 13 April 
2020 
Data provided by author 
FdK. 
Serology (IgG) 0-19y / 20+y 
Hallal et al.42 Preprint Brazil First cases reported 27 
February with local/state 
lockdowns during March 
and April. Some states 
began to relax measures in 
April.  
Nationwide seroprevalence survey in 133 sentinel 
cities in 26 Brazilian states. Randomly selected 
households visited and finger-prick rapid serology 
test used. Total sample was 24,995 with household 
response rate =55%. Children heavily under-





 Rapid lateral flow test used in our 





Preprint Iran Population-based 
seroprevalence study in 5 
counties in Guilan 
province, northern Iran in 
April 2020 – previously 
very high virus prevalence.  
multistage cluster random sampling approach and 
telephone recruitment of head of household. 1 
 
196 /632 approached households participated 





 VivaDiag COVID 19 IgM/IgG 
serology.   
 
Biggs et al.39 Published and 
peer 
reviewed 
Georgia, USA Study undertaken by US 
Centers for Disease 
Control (CDC) to coincide 
with end of shelter in place 
orders (3-30 April).  
Survey of a random sample of households in two 
metropolitan Atlanta countries. 696 persons from  
 
394/1675 households (23.5%) participated. 
Children <18y were 6.9% of sample compared with 




 Total antibody measured using 
VITROS 3600 Immunodiagnostic 
System (Ortho Clinical Diagnostics. 









First case on 26 Feb 2020. 
Schools closed on 16 
March and strict social 
distancing measures 
introduced 20 March. 
Seroprevalence initiated 
using a population-based 
sample in canton.  
Population-based but not fully random sample 
within canton (region). 1300 randomly selected 
adults approached each week for 5 weeks and 
invited to bring all household aged 5+ for serology. 
Only non-symptomatic individuals studied. 
2766/5492 (50.4%) agreed to participate in total, 
and data presented here for first 1360.  
 
16.4% of sample aged 0-19y, similar to population.  
6 April – 
9 May 
2020 
Indeterminate cases were 
treated as negative in 
calculating data for the 
meta-analysis.  
ELISA to spike protein (Euroimmun; 
Lübeck, Germany #EI 2606-9601 G) 
5-19y / 20+y 
Nawa et al.41 Preprint Utsunomiya 
City, Greater 
Tokyo, Japan 
First cases in Japan from 
15 January. All schools 
closed 27 February.  
 
Population-based seroprevalence survey: a random 
sample of 1000 households approached  
 
742/2290 persons (32%) participated.  
13% were <18y – similar to population.  
14 June-5 
July 
 IgG (Shenzhen YHLO Biotech Co., 
Ltd., Shenzhen, China). 
0-17y, 18y+ 
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C. Population-screening studies       
Author Status Location Context Recruitment  Timing of 
survey  
Note Case definition/testing Age: child / adult 
Survey conducted 
between the first and 
second spikes of infection 
in the city.  
Pagani et al.43 Preprint Lombardy, 
Italy 
The town of Castiglione 
d’Adda, 4550 inhabitants 
had high numbers of 
infections from early in the 
pandemic. Local lockdown 
occurred from 23 February 
2020.  
Entire population (all ages) invited to participate: 
recruited 4174 /4550 inhabitants (92%) who had 
rapid capillary testing, of whom a random sample 
of 562 (stratified for age and sex) had form 
serology by venepuncture. 
 
0-19y made up 12% of the rapid and formal 
serology samples.  
June 
2020 
22% of population showed 
overall positivity (22.2% on 
rapid test, 22.6% on formal 
serology)  
 
Rapid test used in meta-
analyses here as findings 
from formal serology were 
highly similar. 
Rapid capillary testing: lateral-flow 
immunocromatographic test (Prima 
Lab, Switzerland)  
 
Serology: CLIA, IgG anti-SARS-CoV-
2, Abbott, USA), 
0-19 / 20+ 




(CoNAN study) in in the 
previously quarantined 
community Neustadt-am-
Rennsteig,  from, six weeks 
after a SARS-CoV-2 
outbreak (March 22nd). 
Local lockdown initiated.  
All community households invited.  
Enrolled 626/883 = 71% of community.  
 
Focus on child participation and blood collection to 
be representative. Children 1-17y were 9.5% of the 
sample  
 
620 gave blood and 600 participants had all 6 




 Serology by 6 quantification 
methods: 2 ELISA and 4 
immunoassay. EDI Novel 
Coronavirus SARS-CoV-2 IgG; 
ELISA kit (Epitope Diagnostics Inc., 
San Diego, USA), SARS-CoV-2 IgG 
ELISA kit ; (Euroimmun, Lübeck, 
Germany), SARS-CoV-2 S1/S2 IgG 
CLIA kit (DiaSorin, Saluggia, Italy), ; 
2019-nCoV IgG kit (Snibe Co., Ltd., 
Shenzhen, China), SARS-CoV-2 IgG 
CMIA kit (Abbott);  Chicago, USA) 
and Elecsys Anti-SARS-CoV-2 kit 
(Roche, Basel Switzerland).  





Carnival held on 15 
February. Strict local social 
distancing measures 
introduced on 28 February 
due to local outbreak and 
deaths.  
A random sample of 600 households was invited to 
participate and 1007 individuals from 405 
households participated. 919 provided serology 
data. 5-14y olds made up 6.0% of sample.  
30 March 
– 7 April 
2020 
62% of the 88 participants 
who could not be assessed 
were children not assessed 
for technical reasons. 
Serology (IgG) 5-14y / 15+y 
 32 
 
